Milton J. Wallace, Director at Catalyst Pharmaceutical Partners, Inc. (CPRX), bought 5,000 shares at $2.94 ($15K) on 2007-09-10, disclosed to the SEC on 2007-09-26.
Open-market purchase of $15k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.93 | 400 | $1K | 8.0% |
| 2 | $2.94 | 4,600 | $14K | 92.0% |
| Total | $2.94 avg | 5,000 | $15K | 100% |
| Filing → |
| CPRX | BUY | 2012-05-29 | $100K | — | Filing → |
| IPII | BUY | 2011-08-18 | $1K | — | Filing → |
| IPII | BUY | 2011-06-02 | $340 | — | Filing → |